Differences in IPSS between the study medication and placebo groups At study enrolment, after six month of study medication or placebo administration, at the end of washout period and after six month of alternative drug treatment [clinicaltrials_resource:1e41703c217e226e559875234dccac2b]
HAREC Clinical Trial Registry
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
Differences in IPSS between the study medication and placebo groups At study enrolment, after six month of study medication or placebo administration, at the end of washout period and after six month of alternative drug treatment [clinicaltrials_resource:1e41703c217e226e559875234dccac2b]
HAREC Clinical Trial Registry
Bio2RDF identifier
1e41703c217e226e559875234dccac2b
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:1e41703c217e226e559875234dccac2b
measure [clinicaltrials_vocabulary:measure]
Differences in IPSS between the study medication and placebo groups
time frame [clinicaltrials_vocabulary:time-frame]
At study enrolment, after six ...... of alternative drug treatment
description
HAREC Clinical Trial Registry
identifier
clinicaltrials_resource:1e41703c217e226e559875234dccac2b
title
Differences in IPSS between th ...... of alternative drug treatment
@en
type
label
Differences in IPSS between th ...... 1703c217e226e559875234dccac2b]
@en